30 Aug - 3 min read

Update on BEE Transaction

Update on BEE Transaction

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831
(“Dis-Chem” or “the Company”)


Shareholders of Dis-Chem are referred to the announcement published on Tuesday, 24 August 2021 in terms
of which shareholders were advised that the Saltzman family through their shareholding vehicle, Ivlyn Local
Investment Holdings Proprietary Limited (“Ivlyn”) (“the Selling Shareholder”) had agreed in principle to
dispose of 86,468,741 Dis-Chem ordinary shares, representing 10.05% of Dis-Chem’s issued share capital to
a BEE Consortium (“the BEE Transaction”).

The BEE Consortium comprises Royal Bafokeng Holdings (“RBH”) and the Black Panther Consortium (“Black
Panther”). Black Panther comprises of GloCap Empowerment Private Equity Fund (“Glocap”), Zungu
Pharmaceuticals (part of Zungu Investments Company (“ZICO”)) and Temo Capital (“Temo”) (part of
Modidima Family Office).

GloCap Empwerment Fund 6 (“Fund6”) is the investor in the BEE Transaction through the Black Panther
Consortium and GloCap is the private equity manager of Fund 6. Larry Nestadt and Joe Mthimunye have an
interest in the economic benefits in the form of a carry in Fund6. Ivan Saltzman is an investor in Fund6.

The BEE Transaction has now been approved by all the BEE Consortium members and the required financing
agreements have been entered into. Accordingly, the BEE Transaction has become unconditional.

The price at which the BEE Transaction was concluded was at a 17.5% discount to the 30-day volume
weighted average price as at the close on Friday, 20 August 2021 and is subject to a lock-in period of the BEE
Consortium for a three year period commencing on Monday, 23 August 2021.

The flow of funds and transfer of Dis-Chem ordinary shares to the BEE Consortium members will take place
on Tuesday, 31 August 2021.

Following the conclusion of the BEE Transaction the shareholding of the BEE Consortium in Dis-Chem would
be as follows:

RBH: 6.63%

Black Panther Consortium: 3.42%

    •   Glocap : 1.34%

    •   Zico: 1.33%

    •   Temo: 0.75%

Dealings in securities

In compliance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited (“JSE”), the following
information is disclosed:

Name of directors:                       Ivan Saltzman and Lynette Saltzman
Name of associate:                       Ivlyn
Class of securities:                     Dis-Chem ordinary shares
Number of shares:                        86,468,741
Price per share:                         R26.05
Value of transaction:                    R2 252 510 703.05
Date of transaction:                     24 August 2021
Nature and extent of interest:           Indirect beneficial

Clearance for the above transaction was obtained in accordance with Dis-Chem’s trading policy.

Change in beneficial interest in securities

In compliance with Section 122(3) (b) of the Companies Act, 2008 (Act 71 of 2008), as amended (“Companies
Act”) and paragraph 3.83(b) of the Listings Requirements of the JSE, shareholders are advised that Ivlyn has
disposed of a beneficial interest in the securities of the Company, such that the total interest in the ordinary
shares of the company held by Ivlyn amounts to 35.15% (previously held 45.20% of the total number of
securities in issue).

As required in terms of section 122(3) (a) of the Companies Act, Dis-Chem will be filing the required notice
with the Takeover Regulation Panel.

30 August 2021

The Standard Bank of South Africa Limited

Date: 30-08-2021 09:01:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Dis-Chem Pharmacies Limited (JSE:DCP) when you join Listcorp.